Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-05-09 Sale |
2024-05-13 3:57 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
40,000 | $81.38 | $3,255,200 | 844,527 (Indirect Direct) |
View |
2024-05-02 Sale |
2024-05-06 4:45 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer |
1,850 | $85.01 | $157,269 | 97,007 (Direct) |
View |
2024-05-02 Sale |
2024-05-06 4:40 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer |
5,000 | $82.91 | $414,550 | 66,767 (Direct) |
View |
2024-04-11 Sale |
2024-04-15 4:21 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
40,000 | $91.13 | $3,645,000 | 924,527 (Indirect Direct) |
View |
2024-04-10 Sale |
2024-04-12 3:07 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | Burkhart Erin GVP, Chief Accounting Officer |
2,286 | $90 | $205,740 | 16,156 (Direct) |
View |
2024-03-28 Sale |
2024-04-01 4:54 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer |
24,602 | $88.34 | $2,173,341 | 55,856 (Direct) |
View |
2024-03-05 Sale |
2024-03-07 6:54 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | FUCHS HENRY J President, Worldwide R&D |
35,341 | $85.18 | $3,010,396 | 212,117 (Direct) |
View |
2024-03-05 Sale |
2024-03-07 5:35 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
2,000 | $86.11 | $172,223 | 807,736 (Indirect Direct) |
View |
2024-03-05 Sale |
2024-03-07 5:32 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer |
4,000 | $87.07 | $348,280 | 94,047 (Direct) |
View |
2024-02-27 Sale |
2024-02-29 5:05 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
1,000 | $90.35 | $90,350 | 809,736 (Indirect Direct) |
View |
2024-02-08 Sale |
2024-02-12 5:20 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
30,000 | $89.03 | $2,670,750 | 944,135 (Indirect Direct) |
View |
2024-01-09 Sale |
2024-01-11 2:40 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
20,000 | $97.28 | $1,945,700 | 1,004,695 (Indirect Direct) |
View |
2023-12-21 Sale |
2023-12-22 5:14 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
10,000 | $93.99 | $939,900 | 853,645 (Indirect Direct) |
View |
2023-12-13 Sale |
2023-12-14 6:18 pm |
BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer |
13,764 | $95.3 | $1,311,709 | 55,710 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-05-20 Tax Withholding |
2024-05-21 4:09 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
1,202 | $77.05 | 721,325 (Direct) |
View |
2024-05-17 Tax Withholding |
2024-05-20 5:20 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Burkhart Erin GVP, Chief Accounting Officer |
993 | $76.97 | 15,163 (Direct) |
View |
2024-05-09 Exercise |
2024-05-13 3:57 pm |
2014-12-04 2024-06-03 |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
40,000 | $0 | 844,527 (Direct) |
View |
2024-05-09 Exercise |
2024-05-13 3:57 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
40,000 | $63.1 | 844,527 (Direct) |
View |
2024-04-30 Option Award |
2024-05-07 5:58 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer |
245 | $68.65 | 74,132 (Direct) |
View |
2024-05-03 Tax Withholding |
2024-05-07 5:58 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer |
4,440 | $82.44 | 74,132 (Direct) |
View |
2024-04-30 Option Award |
2024-05-06 4:45 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer |
301 | $68.65 | 97,007 (Direct) |
View |
2024-05-02 Exercise |
2024-05-06 4:45 pm |
2014-12-04 2024-06-30 |
BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer |
1,850 | $0 | 97,007 (Direct) |
View |
2024-05-02 Exercise |
2024-05-06 4:45 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer |
1,850 | $63.1 | 97,007 (Direct) |
View |
2024-04-30 Option Award |
2024-05-06 4:40 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer |
300 | $68.65 | 66,767 (Direct) |
View |
2024-04-11 Exercise |
2024-04-15 4:21 pm |
2014-12-04 2024-06-03 |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
40,000 | $0 | 924,527 (Direct) |
View |
2024-04-11 Exercise |
2024-04-15 4:21 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
40,000 | $63.1 | 924,527 (Direct) |
View |
2024-03-18 Exercise |
2024-03-20 5:13 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Slamon Dennis Director |
10,000 | $79.7 | 31,299 (Direct) |
View |
2024-03-18 Tax Withholding |
2024-03-20 5:13 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Slamon Dennis Director |
9,510 | $83.81 | 31,299 (Direct) |
View |
2024-03-18 Exercise |
2024-03-20 5:13 pm |
2014-07-19 2024-03-18 |
BIOMARIN PHARMACEUTICAL INC | BMRN | Slamon Dennis Director |
10,000 | $0 | 31,299 (Direct) |
View |
2024-03-18 Tax Withholding |
2024-03-19 8:55 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Burkhart Erin GVP, Chief Accounting Officer |
372 | $83.87 | 25,492 (Direct) |
View |
2024-03-15 Option Award |
2024-03-19 8:55 pm |
2025-03-15 2034-03-14 |
BIOMARIN PHARMACEUTICAL INC | BMRN | Burkhart Erin GVP, Chief Accounting Officer |
11,770 | $0 | 25,492 (Direct) |
View |
2024-03-15 Tax Withholding |
2024-03-19 8:53 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer |
21,699 | $83.87 | 103,448 (Direct) |
View |
2024-03-15 Option Award |
2024-03-19 8:53 pm |
2025-03-15 2034-03-14 |
BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer |
33,250 | $0 | 103,448 (Direct) |
View |
2024-03-15 Tax Withholding |
2024-03-19 8:50 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer |
20,424 | $83.87 | 101,957 (Direct) |
View |
2024-03-15 Option Award |
2024-03-19 8:50 pm |
2025-03-15 2034-03-14 |
BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer |
34,180 | $0 | 101,957 (Direct) |
View |
2024-03-15 Tax Withholding |
2024-03-19 8:48 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer |
20,789 | $83.87 | 97,399 (Direct) |
View |
2024-03-15 Option Award |
2024-03-19 8:48 pm |
2025-03-15 2034-03-14 |
BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer |
36,940 | $0 | 97,399 (Direct) |
View |
2024-03-15 Tax Withholding |
2024-03-19 8:46 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | FUCHS HENRY J President, Worldwide R&D |
33,485 | $83.87 | 237,732 (Direct) |
View |
2024-03-15 Option Award |
2024-03-19 8:46 pm |
2025-03-15 2034-03-14 |
BIOMARIN PHARMACEUTICAL INC | BMRN | FUCHS HENRY J President, Worldwide R&D |
59,100 | $0 | 237,732 (Direct) |
View |
2024-03-15 Option Award |
2024-03-19 8:42 pm |
2025-03-15 2034-03-14 |
BIOMARIN PHARMACEUTICAL INC | BMRN | Hardy Alexander Chief Executive Officer |
76,830 | $0 | 192,201 (Direct) |
View |
2024-03-15 Tax Withholding |
2024-03-19 8:40 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
85,209 | $83.87 | 722,527 (Direct) |
View |
2024-03-15 Tax Withholding |
2024-03-19 8:36 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer |
22,580 | $83.87 | 71,467 (Direct) |
View |
2024-02-27 Option Award |
2024-02-29 5:18 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer |
35,125 | $0 | 81,248 (Direct) |
View |
2024-02-27 Option Award |
2024-02-29 5:16 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Davis George Eric EVP, Chief Legal Officer |
36,187 | $0 | 91,897 (Direct) |
View |
2024-02-27 Option Award |
2024-02-29 5:14 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Guyer Charles Greg EVP, Chief Technical Officer |
36,187 | $0 | 88,201 (Direct) |
View |
2024-02-27 Option Award |
2024-02-29 5:12 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Ajer Jeffrey Robert EVP, Chief Commercial Officer |
37,243 | $0 | 98,047 (Direct) |
View |
2024-02-27 Option Award |
2024-02-29 5:10 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | FUCHS HENRY J President, Worldwide R&D |
53,204 | $0 | 247,458 (Direct) |
View |
2024-02-27 Option Award |
2024-02-29 5:05 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
143,601 | $0 | 809,736 (Direct) |
View |
2024-02-08 Exercise |
2024-02-12 5:20 pm |
2014-12-04 2024-06-03 |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
30,000 | $0 | 944,135 (Direct) |
View |
2024-01-18 Acquisition |
2024-02-12 5:20 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
40 | $92.6 | 944,135 (Direct) |
View |
2024-02-08 Exercise |
2024-02-12 5:20 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
30,000 | $63.1 | 944,135 (Direct) |
View |
Ownership |
2024-02-12 3:24 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
0 | $0 | 667,095 (Indirect) |
View |
2023-02-06 Ownership |
2024-02-12 3:24 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
5,600 | $0 | 667,095 (Direct) |
View |
2023-04-28 Ownership |
2024-02-12 3:04 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Mueller Brian EVP, Chief Financial Officer |
318 | $66.88 | 46,123 (Direct) |
View |
2024-01-08 Gift |
2024-01-23 7:47 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | MEIER RICHARD A Director |
3,000 | $0 | 112,547 (Direct) |
View |
2024-01-09 Exercise |
2024-01-11 2:40 pm |
2014-12-04 2024-06-03 |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
20,000 | $0 | 1,004,695 (Direct) |
View |
2024-01-08 Acquisition |
2024-01-11 2:40 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
50 | $99.05 | 1,004,695 (Direct) |
View |
2024-01-09 Exercise |
2024-01-11 2:40 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
20,000 | $63.1 | 1,004,695 (Direct) |
View |
2023-12-27 Option Award |
2023-12-28 1:18 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Bodem Barbara W. Director |
2,180 | $0 | 2,180 (Direct) |
View |
2023-12-27 Option Award |
2023-12-28 1:13 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Enyedy Mark J Director |
2,180 | $0 | 2,180 (Direct) |
View |
2023-12-27 Option Award |
2023-12-28 1:03 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | Countouriotis Athena Director |
2,180 | $0 | 2,180 (Direct) |
View |
2023-12-21 Exercise |
2023-12-22 5:14 pm |
2014-12-04 2024-06-03 |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
10,000 | $0 | 853,645 (Direct) |
View |
2023-12-21 Exercise |
2023-12-22 5:14 pm |
N/A N/A |
BIOMARIN PHARMACEUTICAL INC | BMRN | BIENAIME JEAN JACQUES Director |
10,000 | $63.1 | 853,645 (Direct) |
View |